コンテンツへスキップ
Merck
  • Type I PRMT Inhibition Protects Against C9ORF72 Arginine-Rich Dipeptide Repeat Toxicity.

Type I PRMT Inhibition Protects Against C9ORF72 Arginine-Rich Dipeptide Repeat Toxicity.

Frontiers in pharmacology (2020-10-06)
Alan S Premasiri, Anna L Gill, Fernando G Vieira
要旨

Repeat expansion mutations in the C9ORF72 gene are the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Repeat-associated non-AUG translation of this expansion produces dipeptide repeat proteins (DRPs). The arginine containing DRPs, polyGR and polyPR, are consistently reported to be the most toxic. Here we demonstrated that small molecule inhibition of type I protein arginine methyltransferases (PRMT) protects against polyGR and polyPR toxicity. Furthermore, our findings suggest that asymmetric dimethylation of polyGR and polyPR by Type I PRMTs plays important roles in their cytotoxicity.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
Triton X-100, laboratory grade
カタログ番号
容量
在庫状況
単価
数量
Sigma-Aldrich
抗C9ORF72/C9RANT(poly-GR)抗体 クローン5A2, clone 5A2, 1 mg/mL, from rat
カタログ番号
容量
在庫状況
単価
数量